CO6311109A2 - Nuevas secuencias de la brachyspira composiciones inmunogenicas metodos para la preparacion y su uso - Google Patents
Nuevas secuencias de la brachyspira composiciones inmunogenicas metodos para la preparacion y su usoInfo
- Publication number
- CO6311109A2 CO6311109A2 CO10118506A CO10118506A CO6311109A2 CO 6311109 A2 CO6311109 A2 CO 6311109A2 CO 10118506 A CO10118506 A CO 10118506A CO 10118506 A CO10118506 A CO 10118506A CO 6311109 A2 CO6311109 A2 CO 6311109A2
- Authority
- CO
- Colombia
- Prior art keywords
- brachyspira
- preparation
- immunogenic compositions
- new sequences
- compositions methods
- Prior art date
Links
- 241001148534 Brachyspira Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000589893 Brachyspira hyodysenteriae Species 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Se describen el nuevo Polinucleótido y los aminoácidos de Brachyspira hyodysenteriae. Esas secuencias son de utilidad para el diagnostico de la enfermedad por Brachyspira hyodysenteriae en los animales y como un tratamiento terapéutico o tratamiento profiláctico de la enfermedad causada por la Brachyspira hyodysenteriae en los animales. Estas secuencias también pueden ser de utilidad para el diagnostico y tratamientos terapéuticos y /o profiláctico de enfermedades causadas en animales por otras especies de Brachyspira.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08152093A EP2363407A1 (en) | 2008-02-28 | 2008-02-28 | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6311109A2 true CO6311109A2 (es) | 2011-08-22 |
Family
ID=39272375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO10118506A CO6311109A2 (es) | 2008-02-28 | 2010-09-24 | Nuevas secuencias de la brachyspira composiciones inmunogenicas metodos para la preparacion y su uso |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110064761A1 (es) |
EP (1) | EP2363407A1 (es) |
JP (1) | JP2011512803A (es) |
KR (1) | KR20100135762A (es) |
AU (1) | AU2009219116A1 (es) |
BR (1) | BRPI0908410A2 (es) |
CA (1) | CA2716973A1 (es) |
CO (1) | CO6311109A2 (es) |
MX (1) | MX2010009516A (es) |
WO (1) | WO2009105833A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101821284B (zh) * | 2007-08-03 | 2014-11-19 | 贝林格尔·英格海姆维特梅迪卡有限公司 | 猪痢疾短螺旋体的基因和蛋白质及其用途 |
EP2593550A4 (en) * | 2010-07-16 | 2014-01-22 | Univ Saskatchewan | DIAGNOSTIC METHOD OF COLITIS |
WO2014096013A1 (en) | 2012-12-21 | 2014-06-26 | Boehringer Ingelheim Vetmedica Gmbh | Novel recombinant outer membrane proteins from brachyspira hyodysenteriae and uses thereof |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622871A (en) | 1987-04-27 | 1997-04-22 | Unilever Patent Holdings B.V. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
USRE31006E (en) | 1968-09-24 | 1982-08-03 | Akzona Incorporated | Process for the demonstration and determination of reaction components having specific binding affinity for each other |
US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4491632A (en) | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
EP0043718B1 (en) | 1980-07-07 | 1984-11-28 | National Research Development Corporation | Improvements in or relating to cell lines |
US4341761A (en) | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
US4466917A (en) | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
US4493890A (en) | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
US4451570A (en) | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
US4399121A (en) | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
US4427783A (en) | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4632901A (en) | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
CA1319101C (en) | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
US4870007A (en) | 1987-12-18 | 1989-09-26 | Eastman Kodak Company | Immobilized biotinylated receptor in test device, kit and method for determining a ligand |
US5176910A (en) * | 1989-01-17 | 1993-01-05 | Ml Technology Ventures, L. P. | Treponema hyodysenteriae hemolysin and uses therefor |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
US5273743A (en) | 1990-03-09 | 1993-12-28 | Hybritech Incorporated | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
ZA918426B (en) | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
EP0486106A3 (en) | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
US5612487A (en) | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
US6034298A (en) | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5712118A (en) | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
US6682729B1 (en) | 1995-05-03 | 2004-01-27 | University Of Maryland, Baltimore | Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
US5877159A (en) | 1995-05-03 | 1999-03-02 | University Of Maryland At Baltimore | Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same |
US6150170A (en) | 1998-05-03 | 2000-11-21 | University Of Maryland At Baltimore | Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
US5824538A (en) | 1995-09-06 | 1998-10-20 | The United States Of America As Represented By The Secretary Of The Army | Shigella vector for delivering DNA to a mammalian cell |
SE9602545L (sv) | 1996-06-25 | 1997-12-26 | Michael Mecklenburg | Metod för att diskriminera komplexa biologiska prover |
AU7164998A (en) | 1997-04-28 | 1998-11-24 | B-E Safe, Inc. | Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states |
EP1021548A1 (en) | 1997-10-07 | 2000-07-26 | University Of Maryland Biotechnology Institute | Method for introducing and expressing rna in animal cells |
US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
CA2390716A1 (en) | 1999-09-24 | 2001-04-05 | Alan D. King | Process for enhancing electric field-mediated delivery of biological materials into cells |
AU2001240109A1 (en) | 2000-03-07 | 2001-09-17 | U.S. Army Medical Research Institute Of Infectious Diseases | Dna vaccines against poxviruses |
AU2001250859A1 (en) | 2000-03-16 | 2001-09-24 | Joseph J. Drabick | Method for gene transfection and vaccination through skin using electropermeabilization |
BRPI0708959A2 (pt) * | 2006-03-20 | 2011-06-28 | Novartis Ag | genes e proteìnas de brachyspira hyodysenteriae e uso dos mesmos para diagnóstico e terapia |
CN101821284B (zh) * | 2007-08-03 | 2014-11-19 | 贝林格尔·英格海姆维特梅迪卡有限公司 | 猪痢疾短螺旋体的基因和蛋白质及其用途 |
-
2008
- 2008-02-28 EP EP08152093A patent/EP2363407A1/en not_active Ceased
-
2009
- 2009-02-27 MX MX2010009516A patent/MX2010009516A/es not_active Application Discontinuation
- 2009-02-27 BR BRPI0908410-0A patent/BRPI0908410A2/pt not_active IP Right Cessation
- 2009-02-27 CA CA2716973A patent/CA2716973A1/en not_active Abandoned
- 2009-02-27 KR KR1020107021649A patent/KR20100135762A/ko not_active Application Discontinuation
- 2009-02-27 WO PCT/AU2009/000248 patent/WO2009105833A1/en active Application Filing
- 2009-02-27 AU AU2009219116A patent/AU2009219116A1/en not_active Abandoned
- 2009-02-27 US US12/920,292 patent/US20110064761A1/en not_active Abandoned
- 2009-02-27 JP JP2010547921A patent/JP2011512803A/ja active Pending
-
2010
- 2010-09-24 CO CO10118506A patent/CO6311109A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2009219116A1 (en) | 2009-09-03 |
MX2010009516A (es) | 2010-11-30 |
JP2011512803A (ja) | 2011-04-28 |
WO2009105833A1 (en) | 2009-09-03 |
CA2716973A1 (en) | 2009-09-03 |
EP2363407A1 (en) | 2011-09-07 |
US20110064761A1 (en) | 2011-03-17 |
KR20100135762A (ko) | 2010-12-27 |
BRPI0908410A2 (pt) | 2015-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2011003939A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
UY32427A (es) | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma | |
CR9994A (es) | Vacuna terapéutica | |
CO6331297A2 (es) | Composiciones adyuvantes novedosas | |
EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
CL2013000063A1 (es) | Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion. | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
NI201100082A (es) | Compuestos de isoindolina para uso en el tratamiento de cáncer. | |
CR11042A (es) | Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes | |
DOP2012000299A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
AR058098A1 (es) | Derivados de acidos dicarboxilicos y su uso | |
CO6410279A2 (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
BRPI0923070A2 (pt) | "usos de composições para regeneração e reparo de tecido neural após lesão, as referidas composições, e kit" | |
UY31676A1 (es) | "derivados de 3-metil-imidiazo-[1,2-b]-piridazina" | |
BR112012006283A2 (pt) | formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte | |
CR20110318A (es) | Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos | |
EA201170190A1 (ru) | Фармацевтическая композиция, содержащая экстракт мозга свиньи | |
CL2014000050A1 (es) | Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson. | |
AR053385A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
CL2011000119A1 (es) | Compuestos derivados de triazolo[4,3-a]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
MX2010001381A (es) | Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos. | |
CO6311109A2 (es) | Nuevas secuencias de la brachyspira composiciones inmunogenicas metodos para la preparacion y su uso | |
ECSP12011951A (es) | Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |